Grimm, Kate E MD

NeoGenomics is a leader in oncology diagnostics, offering an extensive array of over 500 tests that encompass all major testing modalities, including single gene molecular testing, immunohistochemistry, flow cytometry, and next-generation sequencing. With a commitment to precision oncology, the company provides personalized diagnostic data and therapeutic guidance to support oncologists in delivering tailored patient care. In addition to its diagnostic capabilities, NeoGenomics collaborates with biopharmaceutical partners to expedite drug development and clinical trials, all while maintaining access to a broad dataset that reflects the diversity of the U.S. population. The company's Patient Support team is dedicated to assisting individuals through complex aspects of cancer testing, insurance, and billing. Generated from the website

Located in Aliso Viejo CA you can find the expertise of Dr. Shalini Verma an M.D. specializing in General Allopathic Medicine. As a medical doctor with a focus on general healthcare Dr. Verma brings a wealth of knowledge and experience to her practice. With a Doctor of Medicine degree under her belt Dr. Verma is dedicated to providing top-notch medical care to her patients. Her practice in Aliso Viejo serves as a cornerstone for those seeking comprehensive and professional healthcare services in the area. Generated from this place's public information

NeoGenomics is a leader in oncology diagnostics, providing an extensive range of over 500 tests that support personalized cancer care. Their advanced testing capabilities encompass various modalities, including molecular testing, immunohistochemistry, and next-generation sequencing, ensuring precision in diagnosing solid tumors and hematologic cancers. Committed to advancing cancer therapy, NeoGenomics collaborates with biopharmaceutical partners to accelerate drug development and clinical trials. Their comprehensive oncology data solutions offer unmatched insights that aid in informed clinical decisions, ultimately enhancing patient outcomes during treatment. Generated from the website